DMC Group, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
DMC Group, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$399,662
+8.9%
3,297
+2.9%
0.37%
+1.9%
Q2 2023$366,922
-17.5%
3,204
-50.4%
0.37%
-18.1%
Q1 2023$444,593
+111326.8%
6,458
+102.1%
0.45%
-0.4%
Q4 2022$399
-99.9%
3,195
+6.3%
0.45%
+12.8%
Q3 2022$330,000
+57.9%
3,006
+9.0%
0.40%
+61.5%
Q2 2022$209,000
+3.5%
2,757
+4.2%
0.25%
+9.3%
Q1 2022$202,0002,6450.23%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders